// App-Quantinova.ai

FRI0236 : FIRST PILOT STUDY OF T1 MAPPING MRI WITH ECV MEASUREMENT OF PERIPHERAL MUSCLE IN SYSTEMIC SCLEROSIS PATIENTS SHOWS DIFFUSE FIBROSIS

Researchers

Presenter

  • R. B. Dumitru

Principal Investigators

  • A. Goodall

  • D. Broadbent

  • A. Kidambi

  • S. Plein

  • F. Del Galdo

  • A. L. Tan

  • J. Biglands

  • M. H. Buch

Medical Centers

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK

  • Medical Physics Department, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

  • Medical Imaging and Medical Physics, Sheffield Teaching Hospital Trust, Sheffield, United Kingdom

  • Leeds Inst of Cardiovascular and Metabolic Med LICAMM, Leeds, United Kingdom

  • Centre for Musculoskeletal Research, School of Biological Sciences, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Genetic Disorder

  • Autoimmune (AI)

Disease

  • Inclusion body myositis

  • Scleroderma

  • Cap myopathy

  • Myositis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved